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Abstract
Background: Transient receptor potential vanilloid subtype 1 (TRPV1) is activated by low pH/
protons and is well known to be involved in hyperalgesia during inflammation. Tumor necrosis
factor α (TNF-α), a proinflammatory cytokine, is involved in nociceptive responses causing
hyperalgesia through TNF receptor type 1 (TNFR1) activation. Reactive oxygen species (ROS)
production is also prominently increased in inflamed tissue. The present study investigated TNFR1
receptors in primary cultured mouse dorsal root ganglion (DRG) neurons after TRPV1 activation
and the involvement of ROS. C57BL/6 mice, both TRPV1 knockout and wild type, were used for
immunofluorescent and live cell imaging. The L4 and L5 DRGs were dissected bilaterally and
cultured overnight. TRPV1 was stimulated with capsaicin or its potent analog, resiniferatoxin. ROS
production was measured with live cell imaging and TNFR1 was detected with
immunofluorescence in DRG primary cultures. The TRPV1 knockout mice, TRPV1 antagonist,
capsazepine, and ROS scavenger, N-tert-Butyl-α-phenylnitrone (PBN), were employed to explore
the functional relationship among TRPV1, ROS and TNFR1 in these studies.
Results: The results demonstrate that TRPV1 activation increases TNFR1 receptors and ROS
generation in primary cultures of mouse DRG neurons. Activated increases in TNFR1 receptors
and ROS production are absent in TRPV1 deficient mice. The PBN blocks increases in TNFR1 and
ROS production induced by capsaicin/resiniferatoxin.
Conclusion: TRPV1 activation increases TNFR1 in cultured mouse DRG neurons through a ROS
signaling pathway, a novel sensitization mechanism in DRG neurons.
Background
Inflammation comes with sensitization of specialized sen-
sory neurons that comprise the nociceptive pathway, leading
to enhanced pain sensation in response to both noxious and
non-noxious stimuli [1]. The transient receptor potential
vanilloid 1 (TRPV1) participates in the development of
chemical and thermal hyperalgesia in inflammation,
through the action of low pH, heat and inflammatory medi-
ators [2]. The most striking feature of TRPV1 knockout mice
is the virtual absence of thermal hypersensitivity in the set-
ting of inflammation [3-6]. Inflammation causes the release
of inflammatory mediators which lower the threshold of
heat stimulation, a process known as heat hyperalgesia
depending on TRPV1 activation [7].
Tumor necrosis factor α (TNF-α) is prominently released
during inflammation and plays an important role in
hyperalgesia in inflammation. Application of TNF-α
Published: 17 June 2009
Molecular Pain 2009, 5:31 doi:10.1186/1744-8069-5-31
Received: 9 March 2009
Accepted: 17 June 2009
This article is available from: http://www.molecularpain.com/content/5/1/31
© 2009 Ma et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Molecular Pain 2009, 5:31 http://www.molecularpain.com/content/5/1/31
Page 2 of 11
(page number not for citation purposes)
enhances calcium currents increasing neuron sensitivity to
the neurotoxin capsaicin in cultures of sensory neurons,
and anti-TNF therapy produces a profound analgesia [8-
11]. TNF-α acts on two distinct subtypes of receptors, TNF
receptor type 1 (TNFR1, p55) and TNF receptor type 2
(TNFR2, p75) [12]. TNFR1 but not TNFR2 neutralizing
antibodies, as well as antisense RNA against TNFR1, can
reduce experimentally induced hyperalgesia [13,14].
TNFR1 immunoreactivity (IR) has been reported in DRG
neurons [15,16]. TNFR1 is increased in nociceptive DRG
neurons and primary afferents by intraperitoneal lipopol-
ysaccharide and after nerve injury in animal models, and
in plasma of patients with pain syndromes, supporting an
important role for TNFR1 in nociception [17-19].
While reactive oxygen species (ROS) are primarily important
for regulating many metabolic cellular activities, excess ROS
have been implicated in neuropathic and inflammatory pain
[20-23]. The transient but dramatic analgesic effect of free-
radical scavengers in pain models suggests that ROS are crit-
ically involved in the generation of pain. Some research on
the signaling pathways has been directed towards document-
ing a role for ROS in cell death and the induction of cell pro-
liferation [24-26]. The effects of ROS may be mediated by
reversible effects on intracellular proteins which lead to alter-
ations in intracellular signaling pathways. Effects of ROS on
aberrant signaling pathways in the nervous system remain to
be determined.
Although some reports show that TNF-α sensitizes TRPV1,
we are interested in the role that TRPV1 activation might
have on TNFR1 as the drive for maintaining nociceptor sen-
sitization. The present study investigated changes in TNFR1
in response to TRPV1 activation in primary DRG neuronal
cultures from both TRPV1 knockout and wild type mice
while monitoring involvement of ROS as a potential drive
in this signaling pathway. Primary DRG neurons were dis-
sected from wild type and TRPV1 knockout C57BL/6 mice.
After overnight incubation, DRG cultures were challenged
with either capsaicin or resiniferatoxin.
Results
Capsaicin induces TNFR1 staining increases in DRG 
neurons from wild type mice
In untreated control primary cultures (24 hr) of DRG neu-
rons from wild type mice, 22.82 ± 1.68% of the neurons
stained for TRPV1, and 9.24 ± 0.27% stained for TNFR1
(Table 1). Photomicrographs shown in Figure 1 illustrate the
green immunofluorescent staining for TRPV1 and red
immunofluorescence identifying TNFR1. In order to explore
expression of TNFR1 in mouse DRG neurons after capsaicin
stimulation, we first examined the co-localization of TRPV1
with TNFR1. Color combination (yellow) microscopy indi-
cated co-localization of TRPV1 and TNFR1 in some mouse
DRG neurons. Dual staining for TRPV1 and TNFR1 was
observed in 41.04 ± 3.94% of TRPV1 immunostaining posi-
tive neurons (Table 1, Fig. 1 Merge) (n = 592). Staining for
TRPV1 and TNFR1 were both observed primarily in small
size neurons. Both capsaicin (1 μM, 20 min) and resinifera-
toxin (200 nM, 20 min) treated groups had significantly
increased TNFR1 staining (capsaicin treated group: 14.62 ±
0.72%, n = 431, P < 0.05; resiniferatoxin treated group: 16.5
± 1.37%, n = 622, P < 0.01), compared with the untreated
group (Fig. 2A, B). There was an increase in the percentage of
neurons showing dual staining for TNFR1 and TRPV1 after
treatment with capsaicin or resiniferatoxin. In the capsaicin
treated group, TNFR1 was identified in 52.89 ± 2.89% of
neurons with TRPV1 immunoreactivity (P < 0.05 compared
with the untreated group), and TNFR1 was found in 73.63 ±
3.54% of TRPV1 neurons in the resiniferatoxin treated group
(P < 0.01 compared with the untreated group; P < 0.05 com-
pared with the capsaicin treated group). This indicates that
primary mouse DRG neurons are more responsive to potent
resiniferatoxin as expected (Table 1). However, the TRPV1
staining was not changed after capsaicin or resiniferatoxin
stimulation (capsaicin treated group: 27.91 ± 2.58%; resinif-
eratoxin treated group: 23.19 ± 2.15% (P > 0.05 for both
compared with the untreated group 22.82 ± 1.68%)) (Table
1).
Capsaicin induced TNFR1 increase is absent in DRG 
neurons of TRPV1 deficient mice
The TNFR1 staining increase after capsaicin (1 μM, 20
min) or resiniferatoxin (200 nM, 20 min) stimulation was
examined in primary cultures of DRG neurons from
TRPV1 knockout mice. No significant change was found
(capsaicin treated group: 10.71 ± 2.93%; resiniferatoxin
treated group: 10.64 ± 2.36% compared with untreated
group: 10.09 ± 1.56%) (Fig. 2C). Immunocytochemical
staining results also confirmed that TRPV1 staining was
absent in cultured DRG neurons of TRPV1 deficient mice
in this study.
Table 1: Percentage of TNFR1 and TRPV1 positive neurons in primary cultures of DRG neurons from wild type mice
TNFR1 TRPV1 Total neurons TNFR1
(% TRPV1)
Positive % of total Positive % of total
Untreated 54 9.24 ± 0.27 128 22.82 ± 1.69 592 41.04 ± 3.94
Capsaicin 60 14.62 ± 0.72 113 27.91 ± 2.58 431 52.89 ± 2.89
Resiniferatoxin 100 16.5 ± 1.37 149 23.19 ± 2.15 622 73.63 ± 3.54
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Capsazepine blocks capsaicin induced TNFR1 increase in 
DRG neurons from wild type mice
Capsazepine, a competitive TRPV1 antagonist, was used
to determine if capsaicin or resiniferatoxin induced
TNFR1 staining in cultured DRG neurons from wild type
mice is mediated through TRPV1 receptor activation. The
results showed that capsazepine (10 μM, 10 min) blocked
TNFR1 increases induced by capsaicin (1 μM, 20 min) or
resiniferatoxin (200 nM, 20 min) respectively (Fig. 2A, B)
(capsazepine plus capsaicin treated group: 9.74 ± 1.85%,
n = 522, P < 0.05 compared with the capsaicin treated
group: 14.62 ± 0.72%; capsazepine plus resiniferatoxin
treated group: 9.34 ± 0.53%, n = 393, P < 0.01 compared
with resiniferatoxin treated group: 16.5 ± 1.37%).
PBN blocks capsaicin induced TNFR1 increase in DRG 
neurons of wild type mice
Pretreatment with PBN (2 mM, 90 min) of cultured DRG
neurons from wild type mice blocked the TNFR1 increases
induced by capsaicin (1 μM) or resiniferatoxin (200 nM)
(Fig. 3). TNFR1 staining in DRG neurons in the PBN plus
capsaicin treated group (12.28 ± 0.36%, n = 395, P < 0.05)
was significantly decreased compared with the capsaicin
treated group (14.62 ± 0.72%) (Fig. 3A). Significantly
decreased TNFR1 staining was also found in DRG neurons
of the PBN plus resiniferatoxin treated group (11.08 ±
1.39%, n = 534, P < 0.01) compared that with resinifera-
toxin treated group (16.5 ± 1.37%) (Fig. 3B).
PBN blocks TRPV1 activated increases in ROS production 
in DRG neurons of wild type mice
Experiments were performed to analyze ROS production
after capsaicin treatment in cultured DRG neurons from
wild type mice. N-tert-butyl-α-phenylnitrone (PBN) is an
electron spin trap with high avidity for free radical species
and functions as an antioxidant in many biological sys-
tems. PBN was used to block ROS production after TRPV1
activation with capsaicin. The color intensity increases in
the microscope image indicate that oxidized derivative
DCF is accumulating in cells (Fig. 4A, B). The DCF accu-
mulation indicates that ROS production is increasing.
Although there was a slow, steady increase of ROS produc-
tion in all neurons in normal physiological experimental
solution due to spontaneous oxidation of the dye over
time, ROS production was significantly increased in cul-
tured DRG neurons after bath application of capsaicin (1
μM) or resiniferatoxin (200 nM) compared with the
untreated neurons. Represented with numerical data at
the 30 minute time point, the ROS fluorescent intensity
for the capsaicin treated group (1037.57 ± 72.15 arbitrary
units, n = 117, P < 0.01) was increased compared to the
untreated group (693.24 ± 75.84, n = 49, P < 0.01); and
ROS was increased in the resiniferatoxin treated group
(1524.56 ± 97.73, n = 104, P < 0.001) compared with the
TRPV1 and TNFR1 in primary cultures of mouse DRG neu-ronsFigure 1
TRPV1 and TNFR1 in primary cultures of mouse 
DRG neurons. Photomicrographs show green TRPV1 
immunofluorescence and red TNFR1 immunofluorescence in 
DRG neurons cultured overnight and then fixed for double 
staining. Merge: Double labeling of TRPV1 and TNFR1 immu-
nostaining (yellow) indicates that TRPV1 and TNFR1 are co-
localized in cultured mouse DRG neurons. Scale Bars: 100 
μm.
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untreated group (980.61 ± 140.60, n = 80, P < 0.001) (Fig.
4C, D). The PBN (2 mM) added 90 min prior to start of
recording abolished ROS production induced by capsai-
cin (1 μM) or resiniferatoxin (200 nM) (PBN plus capsai-
cin treated group: 829.22 ± 51.22, n = 57, P < 0.05
compared with capsaicin treated group; PBN plus resinif-
eratoxin treated group: 835.25 ± 68.83, n = 114, P < 0.001
compared with the resiniferatoxin treated group) (Fig. 4C,
D). ROS production parallels that of untreated control
cultures when treated with PBN only under the same con-
ditions (2 mM for 2 hrs) (Fig. 4C, D). Dose response stud-
ies (Fig. 4E) found that two lower doses of PBN (0.08, 0.4
mM) were also effective in significantly reducing the effect
of resiniferatoxin at 30 min (712.85 ± 53.71 for the 0.08
mM dose of PBN plus resiniferatoxin, n = 24, P < 0.01
compared with resiniferatoxin; 399.55 ± 35.44 for the 0.4
mM dose of PBN plus resiniferatoxin, n = 28, P < 0.001
compared with resiniferatoxin).
Capsaicin increases ROS production in DRG neurons of 
wild type mice
Experiments were performed in cultured DRG neurons
from wild type and TRPV1 knockout mice to determine
ROS production changes after capsaicin or resiniferatoxin
stimulation. In the experiment with wild type mouse DRG
neurons, capsazepine (10 μM) added 10 min prior to start
of recording blocked both capsaicin (1 μM) and resinifer-
atoxin (200 nM) induced increases in ROS production.
Values represent the fluorescent dye intensity at the 30
minute time point (capsazepine plus capsaicin treated
group: 690.56 ± 73.54, n = 47, P < 0.01 compared with
capsaicin treated group: 1037.57 ± 72.15; capsazepine
plus resiniferatoxin treated group: 535.53 ± 25.46, n =
115, P < 0.001 compared with resiniferatoxin treated
group: 1524.56 ± 97.73) (Fig. 5A, B). No changes in ROS
production were detected in DRG neurons from TRPV1
deficient mice (capsaicin treated group: 916.16 ± 105.09;
resiniferatoxin treated group: 975.45 ± 78.10 compared
with untreated group: 683.4 ± 92.15) (Fig. 5C).
Discussion
The present study demonstrates that capsaicin increased
both the TNFR1 staining and ROS production in cultured
DRG neurons from wild type mice through TRPV1 activa-
tion. These phenomena did not occur in TRPV1 deficient
mice. ROS scavenger PBN and TRPV1 antagonist, cap-
sazepine, blocked both the TNFR1 and ROS increases. We
conclude that TRPV1 activation increases TNFR1 through
a signaling pathway driven by ROS generation.
Regulation of TNFR1 by capsaicin
Two subtypes of TNF-α receptors, TNFR1 and TNFR2, are
expressed in peripheral nerves [16]. TNFR1 is expressed in
dorsal root ganglion neurons and plays a potential role in
nociception [13]. In present experiment, TNFR1 is posi-
tively immunostained in 10% of mouse DRG neurons
and almost all of which were small size neurons which
suggests a potential role of TNFR1 in transmission of noci-
ception. TNFR1 in mouse DRG neurons is detected after
sciatic nerve injury but not in control mice [27]. The proc-
ess of dissociating and culturing DRG neurons apparently
increases expression in the cells somewhat since TNFR1 is
not found in normal mouse DRG tissue sections. In rat
inflammation or nerve injury models, increases in TNFR1
expression are reported by several other researchers
[15,17,28-30]. Although there are reports that TNF-α
increases TRPV1 expression through TNF-α receptors and
TRPV1 induced activity is enhanced by TNF-α administra-
tion [31-33], it would be interesting to know if they can
reciprocally regulate one another. The interactive relation-
ship of these two types of receptors will be the target of
further investigation since the present study suggests
TRPV1 activation is inducing TNFR1 increases and/or acti-
vation. In the present study using mouse DRG neuronal
cultures, TNFR1 was significantly increased after stimula-
tion with capsaicin/resiniferatoxin. The responses to cap-
saicin and resiniferatoxin were different since
resiniferatoxin is a more robust agonist for TRPV1. This
result is supported by calcium influx experiments where
resiniferatoxin produces a stronger calcium increase [3].
To confirm that TNFR1 increases induced by capsaicin are
mediated through TRPV1, TRPV1 knockout mice were
employed and additional experiments using capsazepine
were also performed. The results of both these experi-
ments showed that capsaicin/resiniferatoxin induced
increases in TNFR1 in small size DRG neurons co-express-
ing TRPV1, and thus are likely to be nociceptors. This
novel finding of capsaicin induced TNFR1 increases in
cultured mouse DRG neurons has not been reported by
other investigators. The result is in agreement with those
in a rat inflammation model [13]. In CFA arthritis models
in vivo, upregulation of TNFR1 receptors is detected in
peripheral joint tissue, DRG neurons, and small fiber bun-
dles within the root entry zone and fibers bordering the
trigeminal and spinal cord dorsal horn [28,34,35].
During inflammation, high levels of H+ are released from
injured tissue and are important mediators activating
TRPV1. In fact, there are several other mediators activating
TRPV1 such as anandamide and high temperature (43°C)
that are present in inflamed tissue targeted by sensory
nerve terminals. Thermal hyperalgesia and mechanical
allodynia are triggered by TRPV1 over-activation and plas-
tic changes occur in neurons with influxes of ions such as
calcium and sodium. One of the changes we find is
increasing TNFR1 in TRPV1 stained neurons which would
allow neurons to receive information presented in inflam-
matory conditions of which TNF-α plays an important
role. The present study demonstrates the mechanistic link-
age between TNFR1 and TRPV1 activation. TNF-α is pro-
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duced by satellite cells in DRG, Schwann cells in the
peripheral nervous system and local macrophage cells
which increase TNF-α release from peripheral tissue
attracting considerable attention in nociceptive sensation
and inflammatory cell invasion during inflammation.
TNF-α mRNA increases are observed 24 hours after perig-
anglionic injections of complete Freund's adjuvant [36].
Anti-TNF therapy used in treatment of rheumatoid arthri-
tis produces profound analgesia [8,11], indicating that
TNF-α and its receptors may be good therapeutic targets in
other chronic inflammatory pain conditions. The two dis-
tinct subtypes of TNF-α receptors have different functions
in inflammation. TNFR1 functions mainly in the process
that leads to hyperalgesia and most of TNFR2's effects are
involved in immunological responses. While depressing
the immunological responses is also a way to reduce
inflammation induced hyperalgesia, we have chosen to
study neuronal TNFR1 effects in this investigation. Signif-
icant increases in TNFR1 are relevant based on behavioral
evidence showing that antibody against TNFR1 applied to
the epineuria abolishes hyperalgesia caused by chronic
constriction nerve injury [14]. During inflammation,
more TNF-α is released, and TNFR1 expression in neurons
is increasing in proportion to the changes in TNF-α release
from peripheral tissue and DRG satellite cells [8,29]. A
highly active condition in which ROS, TNF-α and TNFR1
are increasing would cause hypersensitivity of peripheral
nerves based on our studies presented here for TRPV1 acti-
vation and others in literature.
PBN blocks capsaicin induced TNFR1 increases
ROS are not only endpoint products of TRPV1 activation
but also signaling pathway elements. The activation of
many types of signaling pathways by ROS involves the
direct modification of membrane lipids/proteins or other
elements of signaling pathways described for ROS [37].
The present study shows PBN blocks TNFR1 increases
induced by capsaicin. It is of considerable interest that
ROS are signaling molecules in the regulation of TNFR1
increase after TRPV1 activation. A similar point was held
in a study by Gao et al. [38] that ROS is involved in
enhancement of NMDA-receptor phosphorylation in ani-
mal pain models. Biologically relevant ROS include the
superoxide radical (•O2-), hydroperoxyl radicals (HO2•),
H2O2 and the hydroxyl radical (•OH). It is not clear at this
time which component is acting as the factor regulating
the TNFR1 in our experiment. Taking ROS in general,
however, ROS play roles either as protein phosphate acti-
vators or in activation of transcription factors to increase
receptor expression. In our experiment, blocking ROS pro-
duction also abolished TNFR1 increases. ROS has been
shown to mediate TRPV1 and neuropeptide-dependent
neurogenic vasodilatation in wild type but not TRPV1
knockout mice [39].
Capsaicin or resiniferatoxin activation of TRPV1 increases TNFR1 staining  cultured mouse DRG neuronsFigure 2
Capsaicin or resiniferatoxin activation of TRPV1 
increases TNFR1 staining in cultured mouse DRG 
neurons. Histograms show the percentage of immunoreac-
tive cells in DRG neuronal cultures. (A) Capsaicin (CAP) sig-
nificantly increases TNFR1 staining (*P < 0.05) and 
capsazepine (CAPP) blocks TNFR1 staining increases induced 
by capsaicin (#P < 0.05 compared to capsaicin alone). (B) Res-
iniferatoxin (RFT) significantly increases TNFR1 (**P < 0.01) 
and capsazepine blocks the TNFR1 increase induced by res-
iniferatoxin (##P < 0.01 compared to resiniferatoxin alone). 
(C) There is no change of TNFR1 in DRG neurons from 
TRPV1 knockout mice after capsaicin or resiniferatoxin stim-
ulation.
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TRPV1 activation induces increases in ROS production
To determine further if ROS is involved in regulation of
TNFR1 increases after TRPV1 activation, we also studied
ROS production after TRPV1 activation by capsaicin in the
mouse DRG neuronal cultures. We assessed cytosolic oxi-
dant activity with use of CM-H2DCFDA, a redox-sensitive
fluorochrome probe to monitor ROS production. CM-
H2DCFDA oxidation to DCF is a nonspecific reaction
used to monitor generation of biological oxidants that
include ROS. It is important to recognize that intracellular
conversion of H2DCFDA to DCF occurs in competition
with other oxidation reactions. The overall rate of
H2DCFDA conversion to DCF therefore reflects a com-
plex, highly dynamic balance between simultaneous rates
of oxidant production and oxidant buffering by multiple
pathways. We interpret this integrated signal as net oxi-
dant activity under a given condition. The data indicate
that ROS production is increased by challenging neurons
with capsaicin/resiniferatoxin. The results from TRPV1
deficient mice show no increase in ROS production after
capsaicin stimulation. The data for the capsazepine pre-
treatment experiment also confirmed this finding. These
data demonstrate that capsaicin initiates ROS generation
through TRPV1 activation. The results are supported in
experiments done on synoviocyte cultures showing that
ROS production was induced by calcium influxes elicited
by TRPV1 activation [40]. It has been established that the
cation channel TRPV1 is activated by capsaicin or proton
and induces calcium influxes [41]. The effective dose used
for activation was selected based on previous studies
reporting maximal but non-desensitizing responses
[3,42,43]. However, the mechanism of generating calcium
influx in response to ROS production increase is still
unclear. Significant increases in ROS production do not
occur in the present study until 30 minutes since ROS lev-
els in cells are tightly regulated. ROS generation during
inflammation has attracted increasing attention in the lit-
erature. It is also known that the ROS scavenger used to
block ROS production also reverses hypersensitivity
[23,44]. While much work has been done in vivo in rat,
our work in cultured mouse DRG neurons challenging
TRPV1 with capsaicin to increase ROS production is simi-
lar to in vivo microenvironment conditions present during
inflammation. The finding that PBN abolished ROS pro-
duction induced by capsaicin in the study further con-
firms that elevated ROS production is triggered by TRPV1
activation. Thus, ROS are implicated as important func-
tional and potentially therapeutic targets influencing neu-
rotransmitter responses, inflammatory mediator receptors
and neurogenic vasodilatation relevant to treatment of
inflammation and pain.
Conclusion
The present study reveals that TRPV1 activation increases
ROS which act as signaling molecules to increase TNFR1
in mouse DRG neurons. Thus, in conditions of injured or
inflamed tissues, TRPV1 activation increases of ROS and
inflammatory mediator TNF-α receptor content could
enhance peripheral nerve sensitization, inflammatory
pain and potentially other pathological events.
Experimental methods
This study was performed in accordance with the Guide for
the Care and Use of Laboratory Animals published by the
National Institutes of Health and was approved by the
The ROS scavenger PBN blocks TNFR1 increases in cultured mouse DRG neurons induced by capsaicin or r inifera oxinFig re 3
The ROS scavenger PBN blocks TNFR1 increases in 
cultured mouse DRG neurons induced by capsaicin 
or resiniferatoxin. Histograms showing the percentage of 
TNFR1 immunoreactive neurons in DRG neuronal cultures. 
(A) Capsaicin significantly increases TNFR1 staining in DRG 
neurons (*P < 0.05), and PBN blocks the TNFR1 increase 
induced by capsaicin (#P < 0.05 compared to capsaicin). (B) 
Resiniferatoxin significantly increases the TNFR1 increase in 
DRG neurons (**P < 0.01). PBN blocks the TNFR1 increase 
induced by resiniferatoxin (##P < 0.01 compared to resinifer-
atoxin). Results indicate that capsaicin and resiniferatoxin 
increase TNFR1 in DRG neurons through a ROS signaling 
pathway.
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Capsaicin or resiniferatoxin increases ROS production in mouse primary DRG culturesFigure 4
Capsaicin or resiniferatoxin increases ROS production in mouse primary DRG cultures. (A) Photomicrographs of 
ROS in mouse DRG in primary cultures at baseline. (B) ROS production increases after resiniferatoxin stimulation. The effects 
are indicated by fluorescent dye intensity changes captured with epifluorescent microscopy and quantified with MetaMorphe 
image analysis. (C) Capsaicin increases ROS production at 30 minutes (**P < 0.01 compared to control) and ROS scavenger 
PBN (2 mM) blocks capsaicin induced ROS production at 30 minutes (#P < 0.05 compared to capsaicin). (D) Resiniferatoxin 
increases ROS production at 30 minutes (***P < 0.001 compared to control) and PBN (2 mM) blocks resiniferatoxin induced 
ROS production at 30 minutes (###P < 0.001 compared to resiniferatoxin). (E) PBN also significantly blocks ROS production at 
two lower doses (0.4 mM (***P < 0.001 compared to resiniferatoxin) and 0.08 mM (**P < 0.01 compared to resiniferatoxin)).
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Capsaicin or resiniferatoxin induces ROS production in cultured mouse DRG neurons through TRPV1 activationFigure 5
Capsaicin or resiniferatoxin induces ROS production in cultured mouse DRG neurons through TRPV1 activa-
tion. (A) Capsaicin significantly increases ROS production and capsazepine blocks capsaicin induced ROS production (30 min-
utes: ##P < 0.01 compared to capsaicin). (B) Resiniferatoxin significantly increases ROS production and resiniferatoxin blocks 
capsaicin induced ROS production (30 minutes: ###P < 0.001 compared to resiniferatoxin). (C) There is no change in ROS pro-
duction in DRG neurons from TRPV1 deficient mice after capsaicin or resiniferatoxin stimulation.
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University of Kentucky Institutional Animal Care and Use
Committee.
Primary DRG neuronal cultures
Male and female TRPV1 knockout or wild type C57BL/6
mice (19 – 20 g, Jackson Lab, as a tissue sharing gift from
Dr. Lu-Yuan Lee) were used in these experiments [42].
Mice were anesthetized and the vertebral columns were
exposed, removed, and put into the ice-cold dissection
solution (NaCl 135, KCl 5, KH2PO4 2, HEPES 10, MgSO4
6, CaCl2 1.5, Glucose 10; in mM) bubbled with 100% O2.
The L4, L5 DRGs were removed from the lumbar spinal
roots and placed into the 30 mm dish with ice-cold dissec-
tion solution. After connective tissues were removed,
DRGs were digested in fresh enzyme solution (10 mg
trypsin+25 mg collagenase in 10 ml dissection solution)
in 25 cm2 flask saturated with O2. After shaking in a warm
water bath (speed 150 rpm, 35°C) for 1 hour, 4 ml of cul-
ture medium (MEM with FBS, antibiotics) were added to
the flask. The cells were transferred into a 15 ml centrifuge
tube and spun at 800 rpm for 5 minutes. The supernatant
was discarded and the cell pellet was re-suspended with
culture medium. DRG cells were plated onto poly-L-
Lysine pre-coated 12 mm glass-bottom home made tissue
culture dish or 12 mm coverslips in 24 well culture plates
(0.2 ml of cell suspension per well). Cultured DRG neu-
rons were maintained in an incubator with 5% CO2, 37°C
overnight and all experiments performed on the subse-
quent day.
Immunofluorescence study
Dissociated DRG neurons were cultured on coverslips in
24-well plates overnight. Cells were stimulated with cap-
saicin (1 μM) or resiniferatoxin (200 nM) for 30 minutes
and then the media was replaced with Dulbecco’s phos-
phate buffered saline (DPBS) for 90 minutes. In some
experiments, ROS scavenger PBN was applied for 90 min-
utes before capsaicin stimulation, or TRPV1 antagonist
capsazepine (10 μM) was administered 10 minutes before
capsaicin stimulation. At the end of incubation, cells were
washed with 0.1 M phosphate buffered saline (PBS,
pH7.4) 3 times × 5 minutes and fixed with 4% parafor-
maldehyde in 0.1 M PBS for 30 minutes. After washing
with PBS, cells were incubated with 3% normal donkey
serum in PBS plus 0.02% Triton X-100 for 30 minutes to
block non-specific protein binding. Then, cells were incu-
bated overnight with the primary antibody diluted in PBS
TritonX-100 plus 1% normal donkey serum at 4°C. The
anti-TRPV1 receptor antibody (VR1 P-19, Santa Cruz, and
affinity purified goat polyclonal antibody against a pep-
tide mapping near the N-terminus of VR1 of rat origin
producing a single band in western blots) was diluted
1:100. The anti-TNFR1 receptor antibody (TNF-R1 H-5,
Santa Cruz), a mouse monoclonal antibody raised against
amino acids 30–301 mapping within the extracellular
domain of TNF-R1 of human origin producing a single
band in western blots, was diluted 1:50. After overnight
incubation, the coverslips were rinsed in PBS 3 times × 5
minutes and incubated with FITC-donkey-anti-goat anti-
body, diluted 1:1000 and Texas Red-donkey-anti-mouse
antibody, diluted 1:800 in PBS Triton-X plus 1% normal
donkey serum for 1 hour at room temperature. For stain-
ing controls, primary antibodies were omitted. The cover-
slips were washed again 3 times × 5 minutes. Thereafter,
the coverslips were mounted face down onto slides with
mounting medium. Five different areas were picked ran-
domly from each coverslip for pictures. MetaMorph
offline software was used for digital image data analysis.
Determination of ROS production by H2DCFDA 
fluorescent probe
All experiments were done at room temperature. Cells
were kept at room temperature for 30 min before replac-
ing culture medium with DPBS, pH 7.4. On the day of the
experiment, the ROS-sensitive fluorescent dye, 5-(and-6)-
chloromethyl-2', 7'-dichlorodihydrofluorescein diacetate,
acetyl ester (CM-H2DCFDA, Invitrogen) was freshly
reconstituted. Cells were pre-loaded with CM-H2DCFDA
in DPBS at a final concentration of 4 μM for 30 min. The
loading buffer was removed and replaced with DPBS
allowing 20 min to 2 h recovery time for cells to exhibit
low levels of esterase activity. ROS production was moni-
tored for 30 minutes in the live cell imaging experiment.
Cells were stimulated with bath application of capsaicin
(1 μM) or resiniferatoxin (200 nM) and in some cases
neurons were pretreated 10 minutes with TRPV1 antago-
nist capsazepine (10 μM) before beginning the recording
and capsaicin stimulation. ROS scavenger N-tert-Butyl-α-
phenylnitrone (PBN, 2 mM) was administered for 90
minutes before capsaicin stimulation.
The change in fluorescent intensity over time is propor-
tional to DCF accumulation, an index of net oxidant activ-
ity in the cytoplasm. Fluorescent imaging was performed
using an Eclipse 2000-S microscope (Nikon) equipped
with a high sensitivity digital monochrome Cool SNAP ES
camera (Photometrics, Tucson, AZ) controlled by Meta-
Morph software (Molecular Devices, Sunnyvale, CA). DCF
was excited at 480 nm and emitted light was collected using
a 520 nm long pass filter. The photos were captured under
10 ms exposure at 1 min intervals for 30 min. Emissions
from DCFH-free buffer are not detectable under these con-
ditions, and background correction is not required. Pho-
tooxidation artifact was controlled by conducting
experiments in a darkened laboratory and by standardizing
excitation parameters to minimize the cumulative deliv-
ered energy. The baseline fluorescent intensity was deter-
mined prior to exposing the cells to experimental
inducements. MetaMorph offline software (Molecular
Devices, Sunnyvale, CA) was used for image data analysis.
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Chemicals
Trypsin, poly-L-Lysine, capsaicin, resiniferatoxin, cap-
sazepine and N-tert-Butyl-α-phenylnitrone were obtained
from Sigma-Aldrich (St. Louis, MO). Collagenase was pur-
chased from Roche Applied Science (Indianapolis, IN). 5-
(and-6)-chloromethyl-2', 7'-dichlorodihydrofluorescein
diacetate, acetyl ester and DPBS were purchased from Inv-
itrogen (Carlsbad, CA). Antibody against TRPV1, anti-
body against TNFR1, FITC-donkey-anti-goat antibody and
Texas Red-donkey-anti-mouse antibody were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA). Mount-
ing medium was purchased from Vector Laboratories
(Burlingame, CA).
Statistics
All data were expressed as mean ± SEM. Comparisons
among multiple means were analyzed with the one-way
ANOVA. Post hoc test was analyzed with the Newman-
Keuls Multiple Comparison test. A P < 0.05 was consid-
ered significant.
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